Sodium-glucose cotransporter 2 inhibitors: efficacious and safe in elderly patients with heart failure

被引:0
|
作者
Patel, Hitesh C. [1 ,2 ,3 ]
Kaye, David M. [1 ,2 ,3 ]
机构
[1] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia
[2] Baker Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia
[3] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
关键词
D O I
10.1002/ejhf.2744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2305 / 2306
页数:2
相关论文
共 50 条
  • [41] Potential global impact of sodium-glucose cotransporter-2 inhibitors in heart failure
    Talha, Khawaja M.
    Butler, Javed
    Greene, Stephen J.
    Aggarwal, Rahul
    Anker, Stefan D.
    Claggett, Brian L.
    Docherty, Kieran F.
    Solomon, Scott D.
    McMurray, John J. V.
    Januzzi, James L.
    Vaduganathan, Muthiah
    Fonarow, Gregg C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (07) : 999 - 1009
  • [42] Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction
    Falk, Jamie
    Potter, Jennifer
    Turgeon, Ricky D.
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (09) : 678 - 678
  • [43] Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
    Paolo Severino
    Andrea D’Amato
    Silvia Prosperi
    Bettina Costi
    Danilo Angotti
    Lucia Ilaria Birtolo
    Cristina Chimenti
    Carlo Lavalle
    Viviana Maestrini
    Massimo Mancone
    Francesco Fedele
    Heart Failure Reviews, 2023, 28 : 709 - 721
  • [44] Meta-Analysis of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure Patients Without Diabetes
    Mohamed, M. G. Mohamed
    Shaikh, Safia
    Osman, Mohammed
    Kheiri, Babikir
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 148 : 175 - 176
  • [45] Prescribing Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Heart Failure With or Without Type 2 Diabetes
    Bermudez, Sarah R.
    Anderson, Joe R.
    Ray, Gretchen
    DIABETES, 2022, 71
  • [46] The Favourable Effects of Sodium-Glucose Cotransporter 2 inhibitors in Chronic Heart Failure Patients - The Fourth Pillar of Heart Failure Management
    Naser, Nabil
    Durak-Nalbantic, Azra
    Pepic, Esad
    Selimovic, Mirsad
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2023, 142 : S39 - S39
  • [47] Genetic Variation in Sodium-glucose Cotransporter 2 and Heart Failure
    Katzmann, Julius L.
    Mason, Amy M.
    Marz, Winfried
    Kleber, Marcus E.
    Niessner, Alexander
    Bluher, Matthias
    Speer, Thimoteus
    Laufs, Ulrich
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (01) : 149 - 158
  • [48] Sodium-Glucose Cotransporter Type 2 Inhibitors Use in Elderly Polypathological Patients with Acute Heart Failure: PROFUND-IC Registry
    Guzman-Carreras, Alicia
    Vellisca-Gonzalez, Andrea Maria
    Molina-Puente, Juan Igor
    Garcia-Alonso, Rocio
    Paz-Cabezas, Mateo
    Sanchez-Sauce, Beatriz
    Aguilar-Rodriguez, Fernando
    Iguaran-Bermudez, Maria Del Rosario
    Andres, Emmanuel
    Lorenzo-Villalba, Noel
    Mendez-Bailon, Manuel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
  • [49] Sodium-Glucose Cotransporter Inhibitors in Heart Failure Access, Economics, and Clinical Promise
    Sandhu, Alexander T.
    Zheng, Jimmy
    JACC-HEART FAILURE, 2024, 12 (09) : 1611 - 1613
  • [50] Evaluation of sodium-glucose cotransporter 2 inhibitors for renal prognosis and mortality in diabetes patients with heart failure on diuretics
    Weng, Yi-Fang
    Chen, Chung-Yu
    Hwang, Shang-Jyh
    Huang, Yaw-Bin
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (04): : 416 - 425